These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6526060)

  • 1. [Correlation of acetylcholine receptor antibodies and clinical severity of myasthenia gravis in combined immunosuppressive therapy].
    Schumm F; Fateh-Moghadam A; Dichgans J
    Eur Arch Psychiatry Neurol Sci; 1984; 234(4):224-30. PubMed ID: 6526060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
    Patzold U; Kalies I; Haas J; Ginda EM
    Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of acetylcholine receptor antibodies in myasthenia gravis].
    Zeitlhofer J; Maida EM; Mamoli B; Mayr N
    Wien Med Wochenschr; 1986 Jul; 136(13):329-32. PubMed ID: 3765651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; The TH
    J Neurol Sci; 1983 Mar; 58(3):371-85. PubMed ID: 6842265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thymectomy and immunosuppressive therapy on anti-neuroblastoma antibody levels in patients with myasthenia gravis.
    Müller KM; Nykyri E; Andersson LC
    Acta Neurol Scand; 1991 May; 83(5):336-42. PubMed ID: 2063657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
    Kuks JB; Oosterhuis HJ; Limburg PC; The TH
    J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.
    Wang L; Wang S; Yang H; Han J; Zhao X; Han S; Zhang Y; Lv J; Zhang J; Li M; Ji Y; Zhou S; He X; Fang H; Yang J; Zhang Y; Zhang Q; Gao P; Gao F
    Brain Behav; 2021 Jul; 11(7):e02203. PubMed ID: 34075720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.
    Vincent A; Newsom-Davis J; Newton P; Beck N
    Neurology; 1983 Oct; 33(10):1276-82. PubMed ID: 6684222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis.
    Olanow CW; Wechsler AS; Roses AD
    Ann Surg; 1982 Aug; 196(2):113-21. PubMed ID: 7092360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term change of anti-acetylcholine receptor antibody in patients with myasthenia gravis after thymectomy.
    Hayashi M; Manabe K; Takaoka T; Yamada I; Kida K; Matsuda H; Yoshinaga J
    Acta Paediatr Jpn; 1995 Jun; 37(3):362-6. PubMed ID: 7645389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune response to acetylcholine receptor in myasthenia gravis: II. Thymectomy and corticosteroids.
    Morgutti M; Conti-Tronconi BM; Sghirlanzoni A; Clementi F
    Neurology; 1979 May; 29(5):734-8. PubMed ID: 571572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine in myasthenia gravis: observations in 41 patients and a review of literature.
    Kuks JB; Djojoatmodjo S; Oosterhuis HJ
    Neuromuscul Disord; 1991; 1(6):423-31. PubMed ID: 1822354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor antibodies in myasthenia gravis.
    Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
    Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.
    Hawkey CJ; Newsom-Davis J; Vincent A
    J Neurol Neurosurg Psychiatry; 1981 Jun; 44(6):469-75. PubMed ID: 7276959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice advisory: Thymectomy for myasthenia gravis (practice parameter update): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Gronseth GS; Barohn R; Narayanaswami P
    Neurology; 2020 Apr; 94(16):705-709. PubMed ID: 32213645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.